[Effects of growth hormone treatment on anthropometrics, metabolic risk, and body composition variables in small for

Esther Aurensanz Clemente1, Pilar Samper Villagrasa2, Ariadna Ayerza Casas3

  • 1Departamento de Pediatría, Hospital de Barbastro, Barbastro, Huesca, España.

Insights

Recombinant human growth hormone (rhGH) treatment improves height and weight in small for gestational age (SGA) children. While it enhances body composition, close monitoring for potential insulin resistance is crucial.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Small for gestational age (SGA) children without catch-up growth may benefit from recombinant human growth hormone (rhGH) therapy.
  • These children are at an increased risk for developing metabolic syndrome, necessitating careful monitoring during treatment.

Purpose of the Study:

  • To evaluate the effects of rhGH treatment on anthropometric, metabolic, and body composition variables in SGA children.
  • To assess the potential risks and benefits of rhGH therapy in this specific patient population.

Main Methods:

  • A cohort of 28 SGA children (mean age 8.79 years) received rhGH treatment over 4 years.
  • Annual evaluations included anthropometric measurements, metabolic risk markers, and body composition analysis.

Main Results:

  • rhGH significantly improved height, weight, and growth rate without altering BMI.
  • Insulinaemia and HOMA index increased, indicating a trend towards insulin resistance.
  • Body composition showed significant increases in lean mass and reductions in fat mass.

Conclusions:

  • rhGH is effective in improving anthropometric parameters and body composition in SGA children.
  • The observed increase in insulin resistance markers warrants close follow-up to determine long-term implications.
  • Further studies are needed to ascertain if these changes persist into adulthood.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.7K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.2K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.9K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K